Zobrazeno 1 - 10
of 176
pro vyhledávání: '"Kenneth J, Vega"'
Autor:
Luis M. Nieto, Yihienew Bezabih, Sharon I. Narvaez, Chaturia Rouse, Charleigh Perry, Kenneth J. Vega, Jami Kinnucan
Publikováno v:
BMC Gastroenterology, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background/Objectives The Oakland score was developed to predict safe discharge in patients who present to the emergency department with lower gastrointestinal bleeding (LGIB). In this study, we retrospectively evaluated if this score can be
Externí odkaz:
https://doaj.org/article/44e06d44c8084a0bb16f958a97bb82c6
Publikováno v:
BMJ case reports. 15(2)
Autor:
Emily M. Christman, Parthasarathy Chandrakesan, Nathaniel Weygant, John T. Maple, William M. Tierney, Kenneth J. Vega, Courtney W. Houchen
Publikováno v:
Biomarker Research, Vol 7, Iss 1, Pp 1-5 (2019)
Abstract Background Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC) incidence has been increasing in the United States for greater than 30 years. For the majority of EAC patients, treatment is limited and prognosis poor. Doublecortin l
Externí odkaz:
https://doaj.org/article/b5557fca45764624b93dfe0f98caa7ff
Autor:
Courtney W. Houchen, Guangyu An, Michael S. Bronze, James J. Tomasek, Kenneth J. Vega, Edwin Bannerman-Menson, Parthasarathy Chandrakesan, Randal May, William L. Berry, John S. Kaddis, Dongfeng Qu, Yang Ge, Nathaniel Weygant
Doublecortin-like kinase 1 (DCLK1) is a gastrointestinal (GI) tuft cell kinase that has been investigated as a biomarker of cancer stem–like cells in colon and pancreatic cancers. However, its utility as a biomarker may be limited in principle by s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c03fd1353a0072c3e8aaed339ddd654
https://doi.org/10.1158/0008-5472.c.6508002
https://doi.org/10.1158/0008-5472.c.6508002
Autor:
Courtney W. Houchen, Guangyu An, Michael S. Bronze, James J. Tomasek, Kenneth J. Vega, Edwin Bannerman-Menson, Parthasarathy Chandrakesan, Randal May, William L. Berry, John S. Kaddis, Dongfeng Qu, Yang Ge, Nathaniel Weygant
A separate file containging supplemental figure legends as requested by the editorial office
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9ba582a769c646e0dfd4a41d5eb6985
https://doi.org/10.1158/0008-5472.22410486.v1
https://doi.org/10.1158/0008-5472.22410486.v1
Autor:
Courtney W. Houchen, Guangyu An, Michael S. Bronze, James J. Tomasek, Kenneth J. Vega, Edwin Bannerman-Menson, Parthasarathy Chandrakesan, Randal May, William L. Berry, John S. Kaddis, Dongfeng Qu, Yang Ge, Nathaniel Weygant
Supplemental material containing a flowchart for how the 15-miRNA signature was generated, a table of pertinent patient clinical data, and a forest plot of hazard ratios of high-risk colon, pancreatic, and stomach cancer patients with high miRNA sign
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::072388477b8e551e6bb8cdfa9f25f96d
https://doi.org/10.1158/0008-5472.22410483.v1
https://doi.org/10.1158/0008-5472.22410483.v1
Autor:
Praneeth Kudaravalli, Haoran Peng, Kwabena O. Adu-Gyamfi, Zain A. Sobani, Viveksandeep Chandrasekar, Humberto Sifuentes, Kenneth J. Vega, John Erikson L. Yap
Publikováno v:
American Journal of Gastroenterology. 117:e207-e209
Autor:
Bianca N Islam, Sarah K Sharman, Yali Hou, Rui Wang, Justin Ashby, Honglin Li, Kebin Liu, Kenneth J Vega, Darren D Browning
Publikováno v:
Carcinogenesis
A large body of evidence has demonstrated that cyclic-guanosine monophosphate (cGMP), signaling has anti-tumor effects that might be used for colon cancer prevention. The tumor-suppressive mechanism and the signaling components downstream of cGMP rem
Autor:
Yali Hou, Alexis Wren, Namratha Mylarapu, Kaylin Browning, Bianca N. Islam, Rui Wang, Kenneth J. Vega, Darren D. Browning
Publikováno v:
J Pharmacol Exp Ther
There is growing interest in the potential use of phosphodiesterase (PDE) inhibitors for colorectal cancer (CRC) prevention and treatment. The present study has tested the idea that PDE inhibitors inhibit growth and viability of CRC cell lines by inc
Publikováno v:
Gastroenterology Clinics of North America. 50:751-768
Barrett's esophagus (BE) is the precursor lesion for esophageal adenocarcinoma (EAC) development. Unfortunately, BE screening/surveillance has not provided the anticipated EAC reduction benefit. Noninvasive techniques are increasingly available or un